E-LIB Suche - Ergebnisse für: Iwai, Mina

1

Improved Durability of Highly Active IrOx Electrodes for El..:

Shiozawa, Masahito ; Kitazumi, Kosuke ; Iwai, Mina...
Electrocatalysis. 13 (2022) 6 - p. 830-837 , 2022

Link: https://doi.org/10.1007/..

2

The incidence and timing of leukocyte overshoot after pegfi..:

Usami, Eiseki ; Kimura, Michio ; Iwai, Mina...
Journal of Oncology Pharmacy Practice. 25 (2018) 4 - p. 869-874 , 2018

Link: https://doi.org/10.1177/..

3

Evaluation of the role and usefulness of a pharmacist outpa..:

Kimura, Michio ; Go, Makiko ; Iwai, Mina...
Journal of Oncology Pharmacy Practice. 23 (2016) 6 - p. 413-421 , 2016

Link: https://doi.org/10.1177/..

4

Effect of the timing of discontinuation of last-line chemot..:

Kimura, Michio ; Kawachi, Shiori ; Go, Makiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313941/. , 2019

Link: http://www.ncbi.nlm.nih...

5

Tolerability and safety of real-world use of pomalidomide i..:

Usami, Eiseki ; Kimura, Michio ; Takenaka, Shoya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327207/. , 2019

Link: http://www.ncbi.nlm.nih...

6

Pharmaco-economic analysis of adjuvant chemotherapy for sta..:

Iwai, Mina ; Kimura, Michio ; Usami, Eiseki..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431383/. , 2017

Link: http://www.ncbi.nlm.nih...

7

Comparing the cost-effectiveness of FOLFIRINOX, nab-paclita..:

Kurimoto, Machiko ; Kimura, Michio ; Usami, Eiseki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492666/. , 2017

Link: http://www.ncbi.nlm.nih...

8

Analysis of the incidence of tumor lysis syndrome in patien..:

Usami, Eiseki ; Kimura, Michio ; Iwai, Mina..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451858/. , 2017

Link: http://www.ncbi.nlm.nih...

9

Neutropenia as a prognostic factor and safety of second-lin..:

Ikagawa, Makiko ; Kimura, Michio ; Iwai, Mina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998036/. , 2016

Link: http://www.ncbi.nlm.nih...

10

Chemotherapy continuity and incidence of febrile neutropeni..:

USAMI, EISEKI ; KIMURA, MICHIO ; IWAI, MINA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812315/. , 2016

Link: http://www.ncbi.nlm.nih...

11

Comparison of cost-effectiveness of regorafenib and triflur..:

Kimura, Michio ; Usami, Eiseki ; Iwai, Mina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103889/. , 2016

Link: http://www.ncbi.nlm.nih...

12

Adherence and awareness of the therapeutic intent of oral a..:

KIMURA, MICHIO ; NAKASHIMA, KEIJI ; USAMI, EISEKI...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467346/. , 2015

Link: http://www.ncbi.nlm.nih...

13

Oral anticancer agent medication adherence by outpatients:

KIMURA, MICHIO ; USAMI, EISEKI ; IWAI, MINA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

14

Safety and continuity of second- and third-line therapy wit..:

KIMURA, MICHIO ; USAMI, EISEKI ; KANEMATSU, TETSUFUMI...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999116. , 2014

Link: http://www.ncbi.nlm.nih...

15

RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malig..:

Mikami, Masamitsu ; Masuda, Tatsuya ; Kanatani, Takuya...
Molecules and Cells. 45 (2022) 12 - p. 886-895 , 2022

Link: https://doi.org/10.14348..